8-bromo cyclic adenosine monophosphate has been researched along with Heart Failure in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 2 (33.33) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bockus, LB; Humphries, KM | 1 |
Barreto, F; Beetz, N; Gilsbach, R; Hein, L; Herzig, S; Hoppe, UC; Matthes, J; Meissner, M; Meszaros, J; Schwartz, A | 1 |
Haigney, MC; Hanlon, SU; McCurley, JM; Ruknudin, A; Schulze, DH; Wei, SK | 1 |
Matsumori, A; Sasayama, S; Sato, Y | 1 |
Matsumori, A; Nose, Y; Ono, K; Sasayama, S; Sato, Y; Shioi, T | 1 |
Elsner, D; Kromer, EP; Riegger, GA | 1 |
6 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Heart Failure
Article | Year |
---|---|
cAMP-dependent Protein Kinase (PKA) Signaling Is Impaired in the Diabetic Heart.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Catalytic Domain; Cyclic AMP; Cyclic AMP-Dependent Protein Kinase Catalytic Subunits; Cyclic AMP-Dependent Protein Kinase Type II; Cytoplasm; Diabetes Mellitus, Experimental; Disease Models, Animal; Heart Failure; Heart Ventricles; Hemodynamics; Lactates; Lipids; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Phosphofructokinase-2; Phosphorylation; Signal Transduction | 2015 |
Transgenic simulation of human heart failure-like L-type Ca2+-channels: implications for fibrosis and heart rate in mice.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Arrhythmias, Cardiac; Calcium Channels, L-Type; Chronic Disease; Disease Models, Animal; Fibrosis; Heart Failure; Heart Rate; Humans; Mice; Mice, Transgenic; Myocardial Contraction; Myocardium; Myocytes, Cardiac; Okadaic Acid; Patch-Clamp Techniques; Protein Subunits | 2009 |
Protein kinase A hyperphosphorylation increases basal current but decreases beta-adrenergic responsiveness of the sarcolemmal Na+-Ca2+ exchanger in failing pig myocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Agonists; Animals; Cells, Cultured; Colforsin; Cyclic AMP-Dependent Protein Kinases; Female; Heart Failure; Isoproterenol; Male; Membrane Potentials; Myocardium; Myocytes, Cardiac; Okadaic Acid; Phosphoprotein Phosphatases; Phosphorylation; Receptors, Adrenergic, beta; Sarcolemma; Sodium-Calcium Exchanger; Swine | 2003 |
Inotropic agent vesnarinone inhibits cytokine production and E-selectin expression in human umbilical vein endothelial cells.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cardiotonic Agents; Cell Adhesion; Cells, Cultured; Colforsin; Cyclic AMP; Cytokines; Depression, Chemical; E-Selectin; Endothelium, Vascular; Gene Expression Regulation; Heart Failure; Hematopoietic Cell Growth Factors; Humans; Intercellular Adhesion Molecule-1; Interleukin-1; Monocytes; Neutropenia; Pyrazines; Quinolines; Tumor Necrosis Factor-alpha; Umbilical Veins; Vascular Cell Adhesion Molecule-1 | 1995 |
Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; 8-Bromo Cyclic Adenosine Monophosphate; Amrinone; Cells, Cultured; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclic Nucleotide Phosphodiesterases, Type 5; Heart Failure; Humans; Interleukin-1; Interleukin-6; Kinetics; Leukocytes, Mononuclear; Lipopolysaccharides; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Piperidines; Pyrazines; Pyridazines; Quinazolines; Quinolines; Tumor Necrosis Factor-alpha | 1996 |
Hemodynamic, renal, and hormonal effects of 8-Br-cyclic GMP in conscious dogs with and without congestive heart failure.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Blood Pressure; Cardiac Output; Cyclic GMP; Dogs; Female; Heart Failure; Hemodynamics; Hormones; Kidney; Norepinephrine; Renin; Vascular Resistance | 1989 |